Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity
about
Violet and blue light blocking intraocular lenses: photoprotection versus photoreceptionGeographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospectsObject crowding in age-related macular degeneration.Improved contrast of subretinal structures using polarization analysisBlue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular diseaseLaser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing.Age-related macular degeneration. Can we stem this worldwide public health crisis?Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degenerationPerformance of OCT segmentation procedures to assess morphology and extension in geographic atrophy.Foveal-Sparing Scotomas in Advanced Dry Age-Related Macular DegenerationAssociations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular healthNew grading criteria allow for earlier detection of geographic atrophy in clinical trialsFixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study.Aging and visionChanges in retinal sensitivity in geographic atrophy progression as measured by microperimetry.Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.Random word recognition chart helps scotoma assessment in low visionPotential role of lampalizumab for treatment of geographic atrophy.Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular DegenerationVision-targeted health related quality of life in older adults: patient-reported visibility problems in low luminance activities are more likely to decline than daytime activitiesComparing the Shape of Contrast Sensitivity Functions for Normal and Low Vision.Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sampleComparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular HealthVisual Function in Older Eyes in Normal Macular Health: Association with Incident Early Age-Related Macular Degeneration 3 Years Later.The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.Recent perspectives in ocular drug delivery.Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.Intraocular sustained-release delivery systems for triamcinolone acetonide.Measuring contrast sensitivity.Fundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research Foundation.Ultraviolet or blue-filtering intraocular lenses: what is the evidence?Preventive effect of Vaccinium uliginosum L. extract and its fractions on age-related macular degeneration and its action mechanisms.CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular DegenerationVISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration.THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.ASSOCIATION BETWEEN VISUAL FUNCTION AND SUBRETINAL DRUSENOID DEPOSITS IN NORMAL AND EARLY AGE-RELATED MACULAR DEGENERATION EYES.Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy
P2860
Q24676430-8860974A-4F3B-45D3-A0C9-2D314294399FQ26774188-2ED37CD7-47B0-462D-B825-A80AB5A8407EQ30837027-3EDA9211-AAEC-4D6E-9018-5F6FF34909BAQ30978469-C854EDA7-3791-4A96-8495-BEC6EFCDDF14Q31154385-0EADF602-61D5-4DC4-B60B-49E53925FFEBQ31637350-69CE3EF6-B51E-42DF-A1B2-432D4DE25FABQ32063590-E8DF6FD7-817E-4880-955E-DE66D7FF0838Q33230283-4D18CFE1-391F-433A-8F81-8EB2E1777025Q33634466-E3E9B370-83B9-4C25-A2C7-9C788ED2BEABQ33717354-7EBDF6B8-038A-454D-8B4E-C2DDB82622A3Q34003267-BB22788E-97D5-469B-A64F-9E517E724FFEQ34062089-AD9CB62A-9598-43E1-908B-12B9E5B3CC96Q34375094-955112B5-6EC6-40B4-BA50-2CB43658C836Q34626440-C625C850-4323-4863-AA88-9A5F8A819A80Q34645582-B847987A-26C5-456C-A8D9-123496C5DCB2Q34691365-F7472B60-EC86-44B9-97D1-2082C378CB54Q35223438-4C33ED6B-CC77-4940-812B-EDE96316A597Q35746909-42E90435-F3AC-49DF-BFEE-122E8F78EF85Q35937052-02B420DD-5113-40ED-9639-D1E8ED87EFCDQ36069597-4BECDBF7-60C5-4DD6-BA96-000DBC4F56C6Q36504174-466AC739-96E7-4FE4-AB41-772723AA6DC2Q36508205-D6155BC6-F58C-4C24-8606-C21D41948080Q36517825-A94CDF36-60F0-4779-9196-89CD65C9E75EQ36535118-8AB152C9-D9C9-4D19-8E7C-9B8782623246Q36848556-174CECBF-9658-4C1F-8C22-6AA8787D1362Q36924781-C262A719-E24F-49B7-9B96-886C25A6908DQ37256549-07BB898C-6937-47A3-B113-91483D6DCC3EQ37314763-55CDF530-1045-4619-AC51-ACC76CDD9287Q37382114-6B1886DF-D7BD-4608-885C-413E1241BCDFQ38104186-6D2E8660-D182-44FD-A87B-8E40FCADF36AQ38269457-990FABF8-0EC3-4DE3-8E59-1EF25C2B3C00Q38592751-5F7AA7BC-BCEB-43BE-B06E-A76338A2019DQ38818001-9436E330-F119-48C7-A75A-A11D31069A74Q38818680-F10B9F4D-278D-43CF-BEAA-BB4788D5A350Q38837386-37CA781F-BA82-47BA-BC34-5B2C4AB1094DQ38902100-7E91EB68-EEA2-443C-9852-EF5E17698A91Q39014462-C3D2B301-FCBE-43F1-853F-62C076519FEEQ39024579-5526578E-963C-44B6-99F1-6C18567BBF05Q40152725-7DF24B39-41EF-4BEC-8075-E595392B37C5Q40358167-914346F5-2FD3-454A-8AFE-8DC58EC02B60
P2860
Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Visual function abnormalities ...... macula and good visual acuity
@en
type
label
Visual function abnormalities ...... macula and good visual acuity
@en
prefLabel
Visual function abnormalities ...... macula and good visual acuity
@en
P2093
P2860
P1433
P1476
Visual function abnormalities ...... macula and good visual acuity
@en
P2093
B S Hawkins
C A Applegate
D Haselwood
J S Sunness
N M Bressler
P2860
P304
P356
10.1016/S0161-6420(97)30079-7
P577
1997-10-01T00:00:00Z